GeneDx Holdings Corp - Class A

GeneDx Holdings Corp. (Nasdaq: WGS) is a genomic diagnostics company focused on rare disease diagnosis. The company offers ExomeDx and GenomeDx tests — ranked #1 by expert geneticists and granted FDA Breakthrough Device designation — enabling clinicians to deliver precise, fast, and actionable genetic diagnoses. GeneDx operates GeneDx Infinity, described as the world's largest rare disease genomic dataset with over 8 million exomes and genomes, more than 8 million phenotypic datapoints, and over 2.5 million genetic tests processed. The company serves geneticists, pediatric specialists, NICUs, and is expanding into general pediatricians, prenatal care, and adult specialists. GeneDx also provides data and biopharma services leveraging its genomic dataset for drug discovery and clinical trials. The company has diagnosed more than 4,800 genetic diseases and has been operating for over 25 years in the genomics field. Updated Aug 3, 2026